Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Glow LifeTechGLWLF +20.03% 3-Year EBITDA Growth Rate is 55.50% as of Mar. 2026. The stock has 1 warning sign investors should review. Among 1,131 Biotechnology companies, Glow LifeTech ranks better than 88.68% on this metric.
During the past 3 years, the average EBITDA Per Share Growth Rate was 55.50% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 20.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of Glow LifeTech was 56.30% per year. The lowest was -124.60% per year. And the median was -20.85% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Glow LifeTech 3-Year EBITDA Growth Rate Related Terms
GLWLF vs VRTX, REGN, RVMD: 3-Year EBITDA Growth Rate Comparison
For the Biotechnology subindustry, Glow LifeTech's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Glow LifeTech 3-Year EBITDA Growth Rate vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Glow LifeTech's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Glow LifeTech's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 55.50% mean?
Glow LifeTech (GLWLF) has a 3-Year EBITDA Growth Rate of 55.50% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Glow LifeTech and its competitors. According to the industry distribution chart, Glow LifeTech ranks #128 out of 1131 companies in the Biotechnology industry, placing it in the top 11.3%.
Is Glow LifeTech's 3-Year EBITDA Growth Rate too high?
Glow LifeTech's current 3-Year EBITDA Growth Rate is 55.50%. The Biotechnology industry median 3-Year EBITDA Growth Rate is 14.90. Glow LifeTech's value of 55.50% is 272.5% above this industry median. Based on the distribution chart, Glow LifeTech ranks #128 out of 1131 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers.
How does Glow LifeTech's 3-Year EBITDA Growth Rate compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Glow LifeTech ranks #128 out of 1131 companies for 3-Year EBITDA Growth Rate. This places Glow LifeTech in the top 11% of its industry — outperforming the majority of peers. The industry median 3-Year EBITDA Growth Rate is 14.90. Glow LifeTech's value of 55.50% is 272.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Biotechnology company?
The median 3-Year EBITDA Growth Rate among Biotechnology companies is 14.90, based on 1,131 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Glow LifeTech's current 3-Year EBITDA Growth Rate of 55.50% is 272.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Glow LifeTech and its competitors. For the Biotechnology industry, the median 3-Year EBITDA Growth Rate is 14.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Glow LifeTech's current 3-Year EBITDA Growth Rate is 55.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Glow LifeTech stock overvalued right now?
Glow LifeTech (GLWLF) has a current 3-Year EBITDA Growth Rate of 55.50%. The current 3-Year EBITDA Growth Rate is 55.50% and 272.5% above the Biotechnology industry median of 14.90. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Glow LifeTech (GLWLF), the current 3-Year EBITDA Growth Rate is 55.50% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Glow LifeTech Corp is a biotechnology company engaged in the business of secondary processing of ingredients to produce micellized materials from certain vitamins, nutraceuticals, and cannabis extracts. Its plant-based MyCell Technology delivery system transforms poorly absorbed natural compounds into enhanced water-compatible concentrates, unlocking the full healing potential of natural active compounds.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GLWLF has been successfully added to your 
